Ahmed Magdy Rabea, Assistant Professor of Medical Oncology and Hematology at National Cancer Institute, shared on LinkedIn:
“I’m pleased to share that I will be participating in the World Conference on Lung Cancer (WCLC 2026) in Seoul, South Korea, September 12th-15th.
I’m particularly honored to contribute to the program through the Joint IASLC–EMRO Forum: Research and Lung Cancer Screening Insights from IARC, where I will participate as an Abstract Discussant and contribute to the EMRO Guidelines Development and Lung Cancer Screening Focus Group.
I will also be part of the ‘Breathe Better Together’ Networking Session, focusing on collaboration in lung cancer prevention and drug development.
It is a privilege to be part of such an international platform and to engage with colleagues from across the region and around the world. I look forward to exchanging ideas, discussing the latest developments in lung cancer research and screening, and contributing to efforts that can ultimately improve patient care.”
